Search

Search Constraints

You searched for: Author/Creator Cristescu, Razvan

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

5. 80 Evaluation of the trusight oncology 500 assay for routine clinical testing of tumor mutational burden (TMB) and clinical utility for predicting response to pembrolizumab. (10th December 2020)

6. 80 Evaluation of the trusight oncology 500 assay for routine clinical testing of tumor mutational burden (TMB) and clinical utility for predicting response to pembrolizumab. (9th November 2020)

7. Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study. Issue 7 (6th July 2022)

8. Biomarkers predictive of response to pembrolizumab in head and neck cancer. (7th December 2022)

9. Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer. (3rd August 2018)

10. Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model. Issue 10 (26th August 2019)